272 related articles for article (PubMed ID: 24513265)
1. Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.
Zhou Q; Facciponte J; Jin M; Shen Q; Lin Q
Cancer Lett; 2014 Mar; 344(1):13-19. PubMed ID: 24513265
[TBL] [Abstract][Full Text] [Related]
2. Application of germ-free NOD-scid IL2rg
Wu C; Shang H; Jiang X; Wang X; Wei H
Sci China Life Sci; 2021 Apr; 64(4):644-647. PubMed ID: 33644835
[No Abstract] [Full Text] [Related]
3. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.
King M; Pearson T; Shultz LD; Leif J; Bottino R; Trucco M; Atkinson MA; Wasserfall C; Herold KC; Woodland RT; Schmidt MR; Woda BA; Thompson MJ; Rossini AA; Greiner DL
Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436
[TBL] [Abstract][Full Text] [Related]
4. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
5. Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg
Du Y; Wang T; Xu J; Zhao C; Li H; Fu Y; Xu Y; Xie L; Zhao J; Yang W; Yin M; Wen J; Deng H
Protein Cell; 2019 Jan; 10(1):31-42. PubMed ID: 29948854
[TBL] [Abstract][Full Text] [Related]
6. Humanized SCID mouse models for biomedical research.
Pearson T; Greiner DL; Shultz LD
Curr Top Microbiol Immunol; 2008; 324():25-51. PubMed ID: 18481451
[TBL] [Abstract][Full Text] [Related]
7. Humanized mice as a preclinical tool for infectious disease and biomedical research.
Shultz LD; Brehm MA; Bavari S; Greiner DL
Ann N Y Acad Sci; 2011 Dec; 1245():50-4. PubMed ID: 22211979
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg
Wei X; Lai Y; Li B; Qin L; Xu Y; Lin S; Wang S; Wu Q; Liang Q; Huang G; Deng Q; Liu P; Wu D; Lai L; Yao Y; Li P
Sci Rep; 2017 Aug; 7(1):7720. PubMed ID: 28798321
[TBL] [Abstract][Full Text] [Related]
9. Histopathological characteristics of human non-tumor thyroid tissues in a long-term model of adenomatous goiter xenografts in the NOD/Shi-scid, IL-2Rγ(null) mouse.
Fujii E; Kato A; Chen YJ; Matsubara K; Ohnishi Y; Suzuki M
Exp Toxicol Pathol; 2014 Jul; 66(4):203-9. PubMed ID: 24589354
[TBL] [Abstract][Full Text] [Related]
10. Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγnull mice is attributed to a lack of CD11c+B220+CD122+ cells.
Ito R; Katano I; Ida-Tanaka M; Kamisako T; Kawai K; Suemizu H; Aiso S; Ito M
J Immunol; 2012 Nov; 189(9):4313-20. PubMed ID: 23018460
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of human embryonic stem cell-derived endothelial cells in humanized mouse models harboring a human immune system.
Yang HM; Moon SH; Choi YS; Park SJ; Lee YS; Lee HJ; Kim SJ; Chung HM
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2839-49. PubMed ID: 24092748
[TBL] [Abstract][Full Text] [Related]
12. Description of a new xenograft model of metastatic neuroblastoma using NOD/SCID/Il2rg null (NSG) mice.
Sartelet H; Durrieu L; Fontaine F; Nyalendo C; Haddad E
In Vivo; 2012; 26(1):19-29. PubMed ID: 22210712
[TBL] [Abstract][Full Text] [Related]
13. NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models.
Ito M; Kobayashi K; Nakahata T
Curr Top Microbiol Immunol; 2008; 324():53-76. PubMed ID: 18481452
[TBL] [Abstract][Full Text] [Related]
14. Cellular-based therapies to prevent or reduce thrombocytopenia.
Pineault N; Boyer L
Transfusion; 2011 Nov; 51 Suppl 4():72S-81S. PubMed ID: 22074630
[TBL] [Abstract][Full Text] [Related]
15. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three humanized mouse models for adoptive T cell transfer.
Volk A; Hartmann S; Muik A; Geiss Y; Königs C; Dietrich U; von Laer D; Kimpel J
J Gene Med; 2012 Aug; 14(8):540-8. PubMed ID: 22847974
[TBL] [Abstract][Full Text] [Related]
17. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.
Shultz LD; Pearson T; King M; Giassi L; Carney L; Gott B; Lyons B; Rossini AA; Greiner DL
Ann N Y Acad Sci; 2007 Apr; 1103():77-89. PubMed ID: 17332083
[TBL] [Abstract][Full Text] [Related]
18. Humanized mice for human retrovirus infection.
Koyanagi Y; Tanaka Y; Ito M; Yamamoto N
Curr Top Microbiol Immunol; 2008; 324():133-48. PubMed ID: 18481458
[TBL] [Abstract][Full Text] [Related]
19. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.
Maykel J; Liu JH; Li H; Shultz LD; Greiner DL; Houghton J
Dig Dis Sci; 2014 Jun; 59(6):1169-79. PubMed ID: 24798995
[TBL] [Abstract][Full Text] [Related]
20. Engraftment of peripheral blood mononuclear cells from human T-lymphotropic virus type 1 carriers in NOD/SCID/gammac(null) (NOG) mice.
Takajo I; Umeki K; Morishita K; Yamamoto I; Kubuki Y; Hatakeyama K; Kataoka H; Okayama A
Int J Cancer; 2007 Nov; 121(10):2205-11. PubMed ID: 17657714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
